Screening of natural products for therapeutic activity against solid tumors

Indian Journal of Experimental Biology

Volumn 48, Issue 3, 2010, Pages 258-264

  El Menshawi, Bassem S ^a   Fayad, Walid ^b   Mahmoud, Khaled ^a   El Hallouty, Salwa M ^a   El Manawaty, May ^a   Olofsson, Maria Hägg ^b   Linder, Stig ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticancer drugs; Cell based assays; High throughput screening; Natural products

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; CASPASE; PLANT EXTRACT;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HEPG2; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; PATHOLOGY; SPECIES DIFFERENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL PRODUCTS; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HCT116 CELLS; HEP G2 CELLS; HUMANS; NEOPLASMS; PLANT EXTRACTS; SPECIES SPECIFICITY;

ARTEMIA;

EID: 77954262670     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Druker B J, Guilhot F, O'Brien S G, Gathmann I, Kantarjian H, Gattermann N, Deininger M W, Silver R T, Goldman J M, Stone R M, Cervantes F, Hochhaus A, Powell B L, Gabrilove J L, Rousselot P, Reiffers J, Cornelissen J J, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen J L, Radich J P, Simonsson B, Taylor K, Baccarani M, So C, Letvak L & Larson R A, Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia, N EnglJMed, 355 (2006) 2408.
2. Nygren P & Larsson R, Overview of the clinical efficacy of investigational anticancer drugs, J Intern Med, 253 (2003) 46.
3. Kola I & Landis J, Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov, 3 (2004) 711.
4. Hanahan D & Weinberg R A, The hallmarks of cancer, Cell, 100 (2000) 57.
5. Shu Y Z, Recent natural products based drug development: a pharmaceutical industry perspective, J Nat Prod, 61 (1998) 1053.
6. Koehn F E & Carter G T, The evolving role of natural products in drug discovery, Nat Rev Drug Discov, 4 (2005) 206.
7. Srivastava V, Negi A S, Kumar J K, Gupta M M & Khanuja S P, Plant-based anticancer molecules: a chemical and biological profile of some important leads, Bioorg Med Chem, 13(2005)5892.
8. Arcamone F M, From the pigments of the actinomycetes to third generation antitumor anthracyclines, Biochimie, 80(1998)201.
9. Uehara Y, Natural product origins of Hsp90 inhibitors, Curr Cancer Drug Targets, 3 (2003) 325.
10. da Rocha A B, Lopes R M & Schwartsmann G, Natural products in anticancer therapy, Curr Opin Pharmacol, 1 (2001) 364.
11. Roninson I B, Broude E V & Chang B D, If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells, Drug Resist Updat, 4 (2001) 303.
12. Brown J M & Attardi L D, The role of apoptosis in cancer development and treatment response, Nat Rev Cancer, 5(2005)231.
13. Slater T F, Sawyer B & Strauli U, An assay procedure for nicotinamide-adenine dinucleotides in rat liver and other tissues, Arch Int Physiol Biochim, 72 (1964) 427.
14. Shoshan M C, Mandic Havelka A, Neumann F and Linder S, Sense and sensibility: cell death biomarker assays from high-throughput anticancer drug screening to monitoring treatment response, Exp Opinion Drug Discovery, 1 (2006) 585
15. Mosmann T, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65 (1983) 55.
16. Hägg M, Biven K, Ueno T, Rydlander L, Bjorklund P, Wiman K G, Shoshan M & Linder S, A novel high-throughput assay for screening of pro-apoptotic drugs, Invest New Drugs, 20 (2002)253.
17. Harwig J & Scott P M, Brine shrimp (Artemia salina L.) larvae as a screening system for fungal toxins, Appl Microbiol, 21 (1971)1011.
18. Pathak S, Multani A S, Narayan S, Kumar V & Newman R A, Anvirzel an extract of Nerium oleander, induces cell death in human but not murine cancer cells, Anticancer Drugs, 11 (2000)455.
19. Mekhail T, Kaur H, Ganapathi R, Budd G T, Elson P & Bukowski R M, Phase 1 trial of Anvirzel in patients with refractory solid tumors, Invest New Drugs, 24 (2006) 423.
20. Xiao H, Yang C S, Li S, Jin H, Ho C T & Patel T, Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis, Mol Nutr Food Res, 53 (2009) 398.
21. Mousa O, Vuorela P, Kiviranta J, Wahab S A, Hiltunen R & Vuorela H, Bioactivity of certain Egyptian Ficus species, J Ethnopharmacol, 41 (1994) 71.
22. Kaufmann S H & Earnshaw W C, Induction of apoptosis by cancer chemotherapy, Exp Cell Res, 256 (2000) 42.
23. Sutherland R M & Durand R E, Radiation response of multicell spheroids-an in vitro tumour model, Curr Top RadiatResQ, 11 (1976)87.
24. Mueller-Klieser W, Multicellular spheroids. A review on cellular aggregates in cancer research, J Cancer Res Clin Oncol, 113(1987) l0les.
25. Sutherland R M, Cell and environment interactions in tumor microregions: the multicell spheroid model, Science, 240 (1988) 177.
26. Kelm J M, Timmins N E, Brown C J, Fussenegger M & Nielsen L K, Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types, Biotechnol Bioeng, 83 (2003) 173.
27. Herrmann R, Fayad W, Schwarz S, Berndtsson M & Linder S, Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids, J Biomol Screen, 13 (2008) 1.
28. Hägg M, Berndtsson M, Mandic A, Zhou R, Shoshan M C & Linder S, Induction of endoplasmic reticulum stress by ellipticine plant alkaloids, Mol Cancer Ther, 3 (2004) 489.
29. Lamb J, Crawford E D, Peck D, Modell J W, Blat I C, 31 Wrobel M J, Lerner J, Brunet J P, Subramanian A, Ross K N, Reich M, Hieronymus H, Wei G, Armstrong S A, Haggarty S J, demons P A, Wei R, Carr S A, Lander E S & Golub T R, The Connectivity Map: using gene-expression signatures to 32 connect small molecules, genes, and disease, Science, 313 (2006) 1929.
30. Fayad W, Fryknas M, Brnjic S, Olofsson M H, Larsson R & Linder S, Identification of a novel topoisomerase inhibitor effective in cells overespressing drug efflux transporters, PLoS One, 2009 Oct 2;4(10):e7238.
31. Feher M & Schmidt J M, Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry, J Chem Inf Comput Sci, 43 (2003) 218.
32. Ortholand J Y & Ganesan A, Natural products and combinatorial chemistry: back to the future, Curr Opin Chem Biol, 8(2004)271.